发明名称 Therapeutic uses for nitric oxide inhibitors
摘要 The present invention is based on the discovery that nitric oxide (NO) is an important growth regulator in an intact developing organism. In particular, the present invention relates to a method of increasing in a mammal a population of hematopoietic stem cells which are capable of undergoing normal hematopoiesis, differentiation and maturation in hematopoietic tissue, wherein the hematopoietic tissue is contacted with multiple doses of at least one inhibitor of NO, such as one or more inhibitors of nitric oxide synthase (NOS), thereby producing hematopoietic tissue having an increased population of hematopoietic stem cells which are capable of undergoing normal hematopoiesis, differentiation and maturation. The present invention also relates to a method of increasing a population of cells in S phase in a tissue of a mammal, comprising contacting the tissue with multiple doses of at least one inhibitor (one or more) of NO, such as an inhibitor of NOS. The invention also pertains to a method of regenerating tissue in an adult mammal comprising contacting a selected tissue (e.g., blood, skin, bone and digestive epithelium), or precursor cells of the selected tissue, with multiple doses of at least one inhibitor (one or more) of NO, thereby inhibiting differentiation and inducing proliferation of cells of the tissue.
申请公布号 US2003032577(A1) 申请公布日期 2003.02.13
申请号 US20010999779 申请日期 2001.10.25
申请人 COLD SPRING HARBOR LABORATORY 发明人 ENIKOLOPOV GRIGORI N.;PEUNOVA NATALIA I.;KUZIN BORIS A.;CLINE HOLLIS;MICHURINA TATYANA
分类号 A61K31/00;A61K31/155;A61K31/17;A61K31/198;A61K31/216;A61K31/223;(IPC1-7):A61K45/00 主分类号 A61K31/00
代理机构 代理人
主权项
地址